Fresenius Recalls Drug Vials Due To Glass Specs - 47 ABC - Delmarva's Choice

Fresenius Recalls Drug Vials Due To Glass Specs

Posted: Updated:

WASHINGTON (AP) - The American unit of German drugmaker Fresenius is recalling four lots of an injectable drug after finding particles of glass in some vials of the medication.
    
The recall applies to four lots of benztropine mesylate injection, which is used to treat Parkinson's disease and some movement side effects related to epilepsy drugs. The drug is manufactured by Allergy Laboratories Inc. and distributed by Fresenius Kabi. The products may also appear with APP or Nexus Pharmaceuticals listed as the manufacturer on the label. The recalled lot numbers are: 030712, 071212, 090512 and 111412.
    
Fresenius Kabi USA says no adverse reactions or customer complaints have been reported.
    
The company is asking health care professionals to return the products by calling the company at 1-866-716-2459.
    
___
    
On the Web: www.apppharma.com/our-products/product-updates3


(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)

  • ContestsMore>>

  • Spring Gas Giveaway

    Spring Gas Giveaway

    Let WMDT fill up your tank! It's time for our Spring Gas Giveaway! More >>
    Enter for your chance to win a $100 Exxon/Mobil Gas Card!More >>
  • Teacher Who Makes A Difference

    Teacher Who Makes A Difference

    The WMDT 47 Teachers Who Make a Difference Contest is Sponsored by Accurate Optical: "Encouraging children of all ages to come in for an annual eye exam to help them see better in school." Each month weMore >>
    The WMDT 47 "Teachers Who Make a Difference" Sponsored by Accurate Optical Encouraging children of all ages to come in for an annual eye exam to help them see better in school.More >>
Powered by WorldNow
Powered by WorldNow All content © Copyright 2000 - 2014 WorldNow and WMDT. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.